Published in J Thromb Haemost on May 01, 2012
Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin. J Thromb Haemost (2005) 2.70
Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity. J Thromb Haemost (2007) 2.28
Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium. J Biol Chem (2007) 2.01
Multifunctional specificity of the protein C/activated protein C Gla domain. J Biol Chem (2006) 1.81
Extraembryonic expression of EPCR is essential for embryonic viability. Blood (2005) 1.49
Endothelial cell protein C receptor cellular localization and trafficking: potential functional implications. Blood (2009) 1.28
Pharmacokinetics of recombinant activated factor VII (rFVIIa). Semin Thromb Hemost (2000) 1.11
Plasma elimination kinetics for factor VII are independent of its activation to factor VIIa and complex formation with plasma inhibitors. Thromb Haemost (2009) 1.05
Factor VII; its turnover rate and its possible role in thrombogenesis. Thromb Diath Haemorrh (1960) 1.04
Factor VIIa binding to endothelial cell protein C receptor: differences between mouse and human systems. Thromb Haemost (2012) 0.92
Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patients. J Thromb Haemost (2011) 0.91
Factor X and factor VII binding to endothelial protein C receptor differs between species. J Thromb Haemost (2011) 0.91
Clearance of rFVIIa and NN1731 after intravenous administration to Beagle dogs. Eur J Pharm Sci (2011) 0.84
Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med (2001) 4.10
Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci U S A (1981) 3.88
Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem (1982) 3.51
Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration. J Med Chem (2000) 3.29
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest (1987) 3.29
The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V. Biochim Biophys Acta (1979) 2.83
Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin. J Thromb Haemost (2005) 2.70
The regulation of natural anticoagulant pathways. Science (1987) 2.58
The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci U S A (1996) 2.58
Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem (1994) 2.52
Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J Thromb Haemost (2011) 2.51
Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci U S A (1986) 2.43
Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice. J Neurosci (1999) 2.26
The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity. J Biol Chem (1979) 2.21
The conversion of prothrombin to thrombin. I. Characterization of the reaction products formed during the activation of bovine prothrombin. J Biol Chem (1974) 2.19
The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity. J Biol Chem (1991) 2.14
Recurrent thromboembolism in pregnancy and puerperium. Is there a need for thromboprophylaxis? Am J Obstet Gynecol (1989) 2.06
The interaction of a Ca2+-dependent monoclonal antibody with the protein C activation peptide region. Evidence for obligatory Ca2+ binding to both antigen and antibody. J Biol Chem (1988) 2.06
Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J Biol Chem (1982) 2.04
Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med (1984) 1.98
Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. J Biol Chem (1981) 1.94
Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells. J Thromb Haemost (2007) 1.91
Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest (1984) 1.84
Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway. Circulation (1997) 1.81
The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood (2000) 1.80
Proteolytic formation and properties of gamma-carboxyglutamic acid-domainless protein C. J Biol Chem (1983) 1.77
Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C. J Biol Chem (1994) 1.77
Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest (1987) 1.74
Non-hematopoietic EPCR regulates the coagulation and inflammatory responses during endotoxemia. J Thromb Haemost (2007) 1.73
A new carboxylation reaction. The vitamin K-dependent incorporation of H-14-CO3- into prothrombin. J Biol Chem (1975) 1.71
A monoclonal antibody against activated protein C allows rapid detection of activated protein C in plasma and reveals a calcium ion dependent epitope involved in factor Va inactivation. J Thromb Haemost (2003) 1.67
Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects. J Clin Endocrinol Metab (2003) 1.66
A polypeptide region of bovine prothrombin specific for binding to phospholipids. Proc Natl Acad Sci U S A (1973) 1.65
A new vitamin K-dependent protein. A phospholipid-binding zymogen of a serine esterase. J Biol Chem (1976) 1.64
Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood (1989) 1.64
Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem (1989) 1.63
Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood (1992) 1.61
Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost (1991) 1.59
Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem (1990) 1.59
Role of coagulation pathways and treatment with activated protein C in hyperoxic lung injury. Thorax (2008) 1.58
A 23bp insertion in the endothelial protein C receptor (EPCR) gene impairs EPCR function. Thromb Haemost (2001) 1.57
The endothelial cell protein C receptor. Cell surface expression and direct ligand binding by the soluble receptor. J Biol Chem (1996) 1.56
Restoring hemostatic thrombin generation at the time of cutaneous wounding does not normalize healing in hemophilia B. J Thromb Haemost (2007) 1.56
Metalloproteolytic release of endothelial cell protein C receptor. J Biol Chem (2000) 1.54
Vitamin K-dependent carboxylase. Requirements of the rat liver microsomal enzyme system. J Biol Chem (1976) 1.53
Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma. Thromb Haemost (1991) 1.53
Glycosylation of tissue factor is not essential for its transport or functions. J Thromb Haemost (2011) 1.52
Intrauterine death and circulating anticoagulant ("antithromboplastin"). Acta Med Scand (1975) 1.51
Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood (2001) 1.51
Activated protein C inhibits platelet prothrombin-converting activity. Blood (1979) 1.51
The function of calcium in protein C activation by thrombin and the thrombin-thrombomodulin complex can be distinguished by mutational analysis of protein C derivatives. J Biol Chem (1992) 1.50
Protein C activation following coronary artery occlusion in the in situ porcine heart. Circulation (1991) 1.50
Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest (1981) 1.50
Glu-192----Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin. Proc Natl Acad Sci U S A (1991) 1.46
Haemophilia prophylaxis in Sweden. Acta Paediatr Scand (1976) 1.46
The active site of thrombin is altered upon binding to thrombomodulin. Two distinct structural changes are detected by fluorescence, but only one correlates with protein C activation. J Biol Chem (1991) 1.44
Influence of aprotinin, a protease inhibitor, on porcine E. coli shock. Studies on coagulation, fibrinolytic and hemodynamic response. Acta Chir Scand (1989) 1.42
The natural anticoagulant protein S is decreased in male smokers. Am Heart J (1991) 1.41
The Chennai Declaration: a roadmap to tackle the challenge of antimicrobial resistance. Indian J Cancer (2013) 1.40
Studies on the growth, optical, electrical and spectral properties of potassium pentaborate (KB5) single crystals. Spectrochim Acta A Mol Biomol Spectrosc (2007) 1.40
Inflammation, innate immunity and blood coagulation. Hamostaseologie (2010) 1.39
Post-biopsy rise in serum PSA. A potential tool for the dynamic evaluation of prostate cancer/prostatic intraepithelial neoplasia (PIN). Cancer Biol Ther (2003) 1.37
DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. Blood (1991) 1.36
The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex. J Biol Chem (1987) 1.36
Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease. Proc Natl Acad Sci U S A (1989) 1.35
The Ser219-->Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype. J Thromb Haemost (2006) 1.34
An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood (1986) 1.33
Thrombomodulin blocks the ability of thrombin to activate platelets. J Biol Chem (1983) 1.33
Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells. Biochemistry (1988) 1.32
Identification of functional endothelial protein C receptor in human plasma. J Clin Invest (1997) 1.31
Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. Blood (2000) 1.30
Protein C. Prog Hemost Thromb (1984) 1.30
Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function. J Biol Chem (2000) 1.29
Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid. Scand J Haematol (1965) 1.29
The endothelial cell protein C receptor. Inhibition of activated protein C anticoagulant function without modulation of reaction with proteinase inhibitors. J Biol Chem (1996) 1.28
Endogenous activated protein C signaling is critical to protection of mice from lipopolysaccaride-induced septic shock. J Thromb Haemost (2009) 1.28
Melioidosis :an emerging infection in India. J Assoc Physicians India (2013) 1.28
Reconstitution of the human endothelial cell protein C receptor with thrombomodulin in phosphatidylcholine vesicles enhances protein C activation. J Biol Chem (1999) 1.27
Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa). J Thromb Haemost (2009) 1.27
Protein S alters the active site location of activated protein C above the membrane surface. A fluorescence resonance energy transfer study of topography. J Biol Chem (1997) 1.24
Expression and purification of a soluble tissue factor fusion protein with an epitope for an unusual calcium-dependent antibody. Protein Expr Purif (1992) 1.24
The soluble endothelial protein C receptor binds to activated neutrophils: involvement of proteinase-3 and CD11b/CD18. J Immunol (2000) 1.23
Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology (1997) 1.21
The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity. J Biol Chem (1992) 1.21
Activation of protein C in vivo. J Clin Invest (1982) 1.20
Vitamin K-dependent carboxylase. Solubilization and properties. J Biol Chem (1976) 1.20
Endotoxin and thrombin elevate rodent endothelial cell protein C receptor mRNA levels and increase receptor shedding in vivo. Blood (2000) 1.20
Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J Biol Chem (1995) 1.19
Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis. Am J Pathol (2001) 1.19
A 10-kDa cyanogen bromide fragment from the epidermal growth factor homology domain of rabbit thrombomodulin contains the primary thrombin binding site. J Biol Chem (1988) 1.19
Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. J Clin Invest (1993) 1.17
Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. J Clin Invest (1988) 1.17
New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK. Structure (1997) 1.17
Cultured bovine aortic endothelial cells promote activated protein C-protein S-mediated inactivation of factor Va. J Biol Chem (1986) 1.16
Functional and immunologic protein S levels are decreased during pregnancy. Blood (1986) 1.15